MedTrace Logo

Lymphocyte Immunophenotyping in Common Variable Immunodeficiency

NCT01196702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2024-03-26

No results posted yet for this study

Summary

The purpose of this study is to discover if differences in the surface markers of B-cells (antibody producing cells of the immune system) in Common Variable Immune Deficiency (CVID) are related to CVID or its complications/treatment (e.g. bronchiectasis, granulomatous disease, immunoglobulin treatment).

The study hypothesis is that the altered B-cell surface markers are related to CVID, and not to the complications or treatment of CVID.

Conditions

  • Common Variable Immunodeficiency
  • Granulomatous Disease
  • Bronchiectasis
  • Immunoglobulin Treatment

Sponsors & Collaborators

  • Barts & The London NHS Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01196702 on ClinicalTrials.gov